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Abstract
Background Type D personality is an emerging risk factor
in cardiovascular disease. We examined the psychometric
properties of the Danish version of the Type D Scale
(DS14) and the impact of Type D on anxiety and depression
in cardiac patients.
Method Cardiac patients (n=707) completed the DS14, the
Hospital Anxiety and Depression Scale, and the Eysenck
Personality Questionnaire. A subgroup (n=318) also
completed the DS14 at 3 or 12 weeks.
Results The two-factor structure of the DS14 was con-
firmed; the subscales negative affectivity and social
inhibition were shown to be valid, internally consistent
(Cronbach’s α=0.87/0.91; mean inter-item correlations=
0.49/0.59), and stable over 3 and 12 weeks (r=0.85/0.78;
0.83/0.79; ps<0.01). Type D was an independent associate
of anxiety (β, 0.49; p<0.01) and depression (β, 0.47; p<
0.01) in univariable linear regression analysis and remained
a significant independent associate of anxiety (β, 0.26; p<
0.01) and depression (β, 0.17; p<0.01) in adjusted
analyses.
Conclusions The Danish DS14 was shown to be a valid
and reliable measure associated with increased symptoms
of anxiety and depression independent of socio-
demographic and clinical risk factors. The DS14 may be
used in research and clinical practice to identify high-risk
patients.
Keywords Anxiety.Coronaryarterydisease.Depression.
DS14.TypeDpersonality.Validity
Introduction
Psychological risk factors have been implicated in the onset
and progression of cardiovascular disease (CVD) [1–3]
and associated with impaired health status [2, 4, 5]. The
first psychological factor to gain risk factor status was the
Type A Behavior Pattern (TABP), characterized by time
urgency, hostility, and impatience [6]. However, later
inconsistent results in relation to TABP led psychosomatic
research to shift focus from personality factors towards
mood and affective disorders [7]. In this context, depression
is the mood state that has received the most attention.
Generally, depression has been associated with a 2- to 4-
fold risk of mortality [8], an increased risk of impaired
health status [5, 9–11], noncompliance [12, 13], and health-
care consumption [14, 15], although a recent meta-analysis
questions the status of depression as an independent risk
factor in CVD [16].
Currently, there is a resurgence of interest in more
chronic psychological factors, such as personality, in the
context of CVD [9, 10, 17, 18]. A personality approach
may have advantages over a mood state approach, as
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such as acute myocardial infarction (AMI), and to be
confounded by somatic health, including disease severity
[19, 20]. The distressed (Type D) personality is an emerging
risk factor in CVD that has been associated with adverse
prognosis, impaired health status, and a wide range of
emotional distress, such as anxiety and depression [2]. The
Type D construct was developed in patients with ischemic
heart disease, but as shown in a recent review, the construct
has value across CVD patient groups, including peripheral
arterial disease, chronic heart failure (CHF), arrhythmia, and
in patients treated with revascularization procedures [2].
Patients with a Type D personality are characterized
by high scores on the two stable personality traits,
negative affectivity and social inhibition [21]. These
patients have a gloomy outlook on life, tend to feel sad,
and experience increased negative emotions (i.e., high
negative affectivity), while not sharing these emotions
with others due to fears of how others may react (i.e.,
high social inhibition). It is important to emphasize that it
is the co-occurrence of a high score on both traits that
incurs an increased risk of adverse health outcomes, with
recent studies showing that social inhibition moderates
the effect of negative affectivity on prognosis [17, 22]. In
addition, the impact of Type D personality on prognosis is
independent of mood states, such as anxiety and depres-
sion [17, 23] and is not confounded by somatic health,
including disease severity [19, 20]. Type D also distin-
guishes itself from depression and other mood states in
that Type D represents a normal personality construct and
is a chronic risk factor (≥2 years), whereas depression is a
measure of psychopathology and comprises an episodic
risk factor (<2 years) [2].
Type D personality can be assessed with the Type D
Scale (DS14) that was originally developed and validated
in Belgian cardiac patients [21]. Although its predecessor,
the Type D Scale 16 (DS16), was validated in the Danish
context [27], new items were included in the DS14 to
enhance the assessment of negative affectivity and social
inhibition [21]. In addition, the DS14 has advantages over
the DS16, as it is a shorter instrument with an easier
scoring format. Hence, the DS14 is more suitable to use in
clinical and epidemiological research and as a screening
instrument in clinical practice to identify high-risk
patients.
The aim of the current study was (1) to cross-validate the
Danish version of the DS14 in a mixed group of cardiac
patients and (2) to examine the impact of Type D personality
on symptoms of anxiety and depression. Based on previous
research, we expected the Danish DS14 to be a valid and
reliable measure to assess Type D personality and that the
Type D construct would be significantly correlated with
symptoms of anxiety and depression.
Method
Procedure and Participants
From January 2005 till February 2007, a total of 1,138
patients were approached for participation in the current
study, of whom 798 agreed to participate. However, the
data quality was only adequate for 726 of these patients.
Cases without scores on the DS14 were excluded from
statistical analyses (n=19). For all remaining cases, missing
data were imputed using the expectation-maximization
algorithm, which has been demonstrated to be an effective
method of dealing with missing data [24]. Data were not
imputed for the Hospital Anxiety and Depression Scale
(HADS) and the Eysenck Personality Questionnaire (EPQ)
if cases had no scores on these measures. Recruitment was
carried out through two channels. The majority of the
patients were identified through a database of ischemic
heart disease (IHD; n=464) and CHF patients (n=126) at
Holbæk Sygehus, Denmark, and the remainder of patients
(117 CHF patients) were recruited at CHF outpatient clinics
at Aarhus University Hospital (Aarhus Sygehus, Skejby
Sygehus, Aalborg Sygehus) and Odense University Hospi-
tal. Thus, the final sample consisted of a mixed group of
707 cardiac patients (n=243 CHF patients; n=464 IHD
patients), and time since the cardiac event ranged from 0.5
to 32 years (mean (SD)=4.1±3.7). All questionnaires were
filled in at home and returned by post. After 3 or 12 weeks,
questionnaires were mailed to all patients of whom only
318 patients responded.
All patients completed the DS14 and the HADS at
baseline, whereas only those patients recruited through the
outpatient clinics completed the EPQ at baseline (n=117).
All patients participating in the follow-up completed the
DS14 at either 3 weeks (n=214) or 12 weeks (n=117).
Retests were carried out at different time points due to
different logistics in relation to the database and the
outpatient clinics.
The ethics committee in the municipalities of the
participating hospitals approved the study protocol. The
study was conducted conform to the Helsinki Declaration,
and a returned questionnaire was considered the equivalent
of informed consent.
Materials
Socio-Demographic and Clinical Variables
Socio-demographic characteristics (age, gender, marital
status), and smoking status were based on self-report.
Information on clinical characteristics (except smoking
status) was obtained from the patients’ medical records
and included diabetes, hypertension, hypercholesterolemia,
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CHF, and co-morbidity.
Type D Scale
The DS14 is a 14-item self-report measure, consisting of
two seven-item subscales, negative affectivity (NA; e.g., “I
often feel unhappy”) and social inhibition (SI; e.g., “Ia ma
closed person”)[ 21]. Responses are indicated on a five-
point Likert scale from 0 (false) to 4 (true; score range 0–28
for each subscale). A standardized cut-off ≥10 on both
subscales indicates Type D caseness [21] with this cut-off
being accurate in classifying Type D versus non-Type D
[25]. The DS14 has good psychometric properties with
Cronbach’s α=0.88/0.86 and 3-month test–retest reliability
r=0.72/0.82 for the negative affectivity and social inhibi-
tion subscales, respectively [21]. A recent study of a large
sample of AMI patients confirmed the temporal stability of
the taxonomy across 18 months and showed that the DS14
is not confounded by disease severity [20].
Eysenck Personality Questionnaire
The short form of the Eysenck Personality Questionnaire
was used to assess neuroticism (12 items) and extroversion
(12 items) [26]. These subscales were included to evaluate
the convergent validity of the DS14 subscales negative
affectivity and social inhibition, as they comprise theoret-
ically similar constructs, yet are not completely over-
lapping. Hence, the neuroticism and extroversion
subscales of the EPQ cannot substitute the negative
affectivity and social inhibition subscales of the DS14, as
the shared variance has been shown to be below 50%,
indicating that, despite overlap in variance, 50% or more in
the Type D subcomponents cannot be explained by the
EPQ traits of neuroticism and extroversion [21, 27]. All
items are answered with 0 (no) or 1 (yes) (score range 0–
12), with a high score indicating more of the personality
trait. The validity and reliability of the two subscales have
proven satisfactory, with Cronbach’s α ranging from 0.80
to 0.87 for the neuroticism subscale and from 0.72 to 0.88
for the extroversion subscale [26, 28].
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale is a 14-item
self-report measure, consisting of two seven-item subscales
that assess anxiety and depressive symptoms devoid of
somatic symptoms [29]. Responses to items are indicated
on a four-point Likert Scale from 0 to 3 (score range 0–21),
with a high score indicating more symptomatology. A cut-
off score ≥8 was used for both subscales to identify patients
with likely anxiety and depressive symptomatology. This
cut-off has been shown to balance sensitivity and specific-
ity optimally [30]. Previous studies have shown that the two
HADS subscales are internally consistent, with Cronbach’s
α for anxiety (HADS-A)=0.80 and for depression (HADS-
D)=0.81 [31]. A recent review confirmed the validity and
reliability of the HADS across 15 studies, with Cronbach’s
α for HADS-A ranging from 0.68 to 0.93 and for HADS-D
ranging from 0.67 to 0.90 [30].
Statistical Analyses
Two alternative confirmatory factor models were specified
and estimated using LISREL 8.80 [32]. A covariance and
asymptotic weight matrix was computed using PRELIS
2.80 [33]. An asymptotic weight matrix allows for weaker
assumptions regarding the distribution of observed varia-
bles and results in improved fit and test statistics [34, 35].
For the confirmatory factor analysis (CFA), we specified a
one-factor model and a two-factor model based on current
recommendations (DS14-NA: items number 2, 4, 5, 7, 9,
12, 13; DS-SI: items number 1, 3, 6, 8, 10, 11, 14) [21]. All
factors were allowed to correlate, and no correlated errors
were included in any of the models. The models were
estimated using maximum likelihood, and following the
recommendations of Hoyle and Panter [36], we assessed
the goodness of fit for each model using a range of fit
indices including Satorra-Bentler scaled chi-squared (S-B
χ
2), the incremental fit index (IFI) [37], and the compar-
ative fit index (CFI) [38]. A nonsignificant Satorra-Bentler
scaled chi-square and values greater than 0.95 for the IFI
and CFI are considered to reflect acceptable model fit.
Additionally, the root mean square error of approxima-
tion (RMSEA) [39] with 90% confidence intervals (90%
CI) are reported, with values less than 0.05 indicating
close fit and values up to 0.08 indicating reasonable errors
of approximation in the population [40]. The standardized
root mean-square residual (SRMR) [41] has been shown
to be sensitive to model misspecification and its use is
r e c o m m e n d e db yH ua n dB e n t l e r[ 42]. Values less than
0.08 are considered to indicate acceptable model fit [43].
The comparative fit of the models was assessed using the
expected cross validation index (ECVI) [44], an index
used for the purposes of model comparison, with the
smallest value indicating the best fitting model. Cron-
bach’s α and the mean inter-item correlation (MIIC) were
calculated to determine the internal consistency of the
negative affectivity and social inhibition subscales of the
DS14. To determine the convergent validity of the DS14
subscales, correlations were calculated between the nega-
tive affectivity (DS14-NA) and social inhibition (DS14-
SI) subscales, EPQ-Extroversion (EPQ-E) and EPQ-
Neuroticism (EPQ-N), HADS-A, and HADS-D. In addi-
tion, a principal component analysis based on the six
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intra-class correlations (ICC) to examine the temporal
stability of the Type D construct. To further examine the
clinical relevance of the Type D construct in the Danish
setting, we stratified the sample by Type D and compared
Type D and non-Type D patients on anxiety and
depressive symptoms, using multivariable linear regres-
sion. In the multivariable analyses, we adjusted for socio-
demographic characteristics (age, gender, marital status,
and smoking), clinical characteristics (primary diagnosis
(CHF vs. AMI), LVEF, angina, hypertension, hyper-
cholesterolaemia, diabetes, and co-morbidity), and anxiety
or depression, when the measure in question was not the
dependent variable. Secondary analyses, using logistic
regression analyses, were performed to investigate the
impact of Type D on anxiety or depression diagnosis
based on the standardized cut-off ≥8o nt h eH A D S[ 30].
All analyses were performed using SPSS 13.0 for
Windows.
Results
Baseline Characteristics
The prevalence of Type D personality was 16% in the
mixed group of cardiac patients, 18.5% in the CHF patients,
and 15% in the IHD patients. Baseline characteristics
stratified by Type D personality are presented in Table 1.
There were no significant differences between Type D and
non-Type D patients on socio-demographic and clinical
characteristics except for age, with Type D patients being
slightly younger.
Confirmatory Factor Analyses
All fit indices are reported in Table 2. With regard to
meeting the criteria associated with the RMSEA, SRMR,
CFI, and IFI fit indices, the results indicate the two-factor
model to be the better fitting of the models. Although the
chi-square test for both models is large relative to degrees
of freedom and statistically significant, this should not
lead to the rejection of the model, as the large sample size
increases the power of the test [45]. The increased power
of the chi-square test can result in models with no serious
misspecification being rejected, as minor discrepancies
between the sample and the implied covariance matrix are
detected. In addition, the ECVI also indicates the two-
factor model to be a superior solution to the one-factor
model. Taken together, this suggests that the theoretically
driven two-factor model of the DS14 represents the best
description of the current data. The standardized loadings
for the two-factor model of the DS14 are presented in
Table 3. All factor loadings were statistically significant
(p<0.05).
To assess whether our two-factor model was invariant
across diagnostic groups, a multi-group analysis was
performed. A constrained model with all coefficients set
equal across diagnostic groups was compared against an
unconstrained model in which all coefficients were allowed
to vary across diagnostic groups. The model fitted equally
well in both diagnostic groups (S-B χ
2 (12)=15.18, p=
0.23), however, when conducting the same analysis assess-
ing invariance of the two-factor model across gender,
significant differences emerged (S-B χ
2 (12)=58.21, p<
0.01), indicating that the two-factor model did not fit
equally well across gender.
Type D (n=115) Non-Type D (n=592) OR (95% CI) p
Socio-demographic
Age, mean (SD) 64 (10.78) 66 (10.28) 0.98 (0.96–1.00) 0.03*
Males, n (%) 84 (73) 448 (76) 1.16 (0.74–1.82) 0.53
Married/co-habiting, n (%) 81 (73) 442 (78) 0.75 (0.47–1.20) 0.23
Clinical
Diabetes, n (%) 22 (20) 96 (17) 1.20 (0.72–2.02) 0.48
Hypertension, n (%) 49 (65) 245 (68) 0.84 (0.50–1.42) 0.52
Hypercholesterolaemia, n (%) 68 (80) 331 (79) 1.04 (0.58–1.86) 0.90
Angina, n (%) 86 (75) 446 (76) 0.96 (0.61–1.53) 0.88
LVEF, mean (SD) 46 (17.35) 48 (17.34) 1.00 (0.98–1.01) 0.42
CHF, n (%)
2 45 (39) 198 (33) 1.28 (0.85–1.93) 0.24
Co-morbidity, n (%) 43 (37) 194 (33) 1.20 (0.79–1.82) 0.39
Smoking, n (%) 29 (25) 143 (25) 1.05 (0.66–1.67) 0.83
Table 1 Baseline characteristics
stratified by Type D personality
LVEF left ventricular ejection
fraction; CHF chronic heart
failure
*p<0.05
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Cronbach’s α as well as the MIIC was calculated for our
two-factor model. MIIC was used because Cronbach’s α is
highly dependent on the number of items in the scale;
hence, the reliability of Cronbach’s α as a measure of
internal consistency diminishes as the number of scale
items increases [46]. In contrast, MIIC indicates the internal
consistency of a scale irrespective of the number of items.
Cronbach’s α for the NA and SI subscales were 0.87 and
0.91, respectively, and the MIIC for the NA subscale was
0.49 and for the SI subscale 0.59 (Table 2). These
coefficients satisfy the criteria for both Cronbach’s α and
the MIIC [46].
Convergent Validity
The left side of Table 4 presents the correlation matrix for
the DS14, the HADS, and the EPQ subscales. As expected,
there were strong associations between DS14-NA and
HADS-D and HADS-A as well as with EPQ-N ranging
from 0.65 to 0.82, respectively. These associations account
for shared variances ranging between 42% and 67%,
indicating that, although there is considerable overlap
between DS14-NA and the other negative affect measures,
there is still a considerable amount of unshared variance.
There were also strong associations between DS14-SI and
HADS-D, HADS-A, and EPQ-N, ranging from −0.33 to
−0.52, indicating a somewhat smaller strength of associa-
Table 2 Confirmatory factor analysis for the DS14
Model S-B χ
2, df (p) RMSEA 90% CI ECVI 90% CI IFI CFI SRMR
Model 1 (1 factor) 1,620.63, 77 (<0.001) 0.169 (0.16–0.18) 2.37 (2.19–2.57) 0.91 0.91 0.12
Model 2 (2 factors) 385.45, 76 (<0.001) 0.076 (0.069–0.084) 0.63 (0.55–0.72) 0.98 0.98 0.076
S-B χ
2 Satorra-Bentler scaled chi-square, RMSEA root mean square error of approximation, CI confidence intervals, ECVI expected cross
validation index, IFI incremental fit index, CFI comparative fit index, SRMR standardized root mean residual
Table 3 Standardized factor loadings and internal consistency of the DS14
DS14 items NA* SI* Internal Consistency*
Negative affectivity
#2 I often make a fuss about unimportant things 0.75 0.59
#4 I often feel unhappy 0.83 0.54
#5 I am often irritated 0.74 0.56
#7 I take a gloomy view of things 0.80 0.71
#9 I am often in a bad mood 0.85 0.75
#12 I often find myself worrying about something 0.84 0.71
#13 I am often down in the dumps 0.88 0.70
α=0.87
MIIC=0.49
Social inhibition
#1 I make contact easily when I meet people
a 0.66 0.68
#3 I often talk to strangers
a 0.60 0.73
#6 I often feel inhibited in social interactions 0.71 0.66
#8 I find it hard to start a conversation 0.82 0.71
#10 I am a closed kind of person 0.88 0.76
#11 I would rather keep other people at a distance 0.82 0.76
#14 When socializing, I don’t find the right things to talk about 0.81 0.79
α=0.91
MIIC=0.59
MIIC mean inter-item correlation
*p<0.05, all factor loadings statistically significant; factor loadings based on confirmatory factor analysis (CFA) for the total sample
aItems 1 and 3 uses a reverse scoring format, however scores on these items were reversed prior to conducting the CFA
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of extroversion, the EPQ-E showed negative correlations
with all other scales, most significantly with DS14-SI
(−0.64) and least with HADS-A (−0.33). The correlation
between DS14-SI and EPQ-E indicates that the shared
variance is 41%, again suggesting some, but not complete,
overlap between these measures. A principal component
analysis of the six subscales showed that DS14-NA in
concert with HADS-D, HADS-A, and EPQ-N made up one
factor of negative affect, whereas DS14-SI and EPQ-E
loaded on a separate factor of inhibition (Table 4, right).
Hence, the content of the two separate factors extracted was
consistent with the theoretical conceptualization of the Type
D construct (Table 4, right). Taken together, the convergent
validity of the DS14 was confirmed against scales
measuring similar constructs.
Temporal Stability of the Type D Construct
The temporal stability of the DS14 was examined over a short
(3 weeks) and a longer period of time (12 weeks). The mean
(SD) score for DS14-NAwas 7.23 (5.46) and 7.40 (5.39) for
DS14-SI at baseline. Pearson’s correlation for NAwas r=0.85
(N=214, p<0.01) and r=0.83 (N=214, p<.01) for SI
between baseline and 3 weeks. Pearson’s correlation for
NA was r=0.78 (N=117, p<0.01) and r=0.79 (N=117,
p<.01) for SI between baseline and 12 weeks. Intra-class
correlation using a two-way mixed effects model, type
consistency, and average measures confirmed these results
at both 3 weeks (NA (ICC=0.92); SI (ICC=0.91)) and
12 weeks (NA (ICC=0.87); SI (ICC=0.88)). Taken together,
these results confirm the temporal stability of the DS14.
Association of Type D with Symptoms of Anxiety
and Depression
The prevalence rates of anxiety and depression in Type D
and non-Type D patients are depicted in Fig. 1. Univariable
linear regression analyses showed that Type D personality
was associated with an increased risk of anxiety (β, 0.49;
p<.001) and depression (β, 0.47; p<.001) as measured by
HADS. Logistic regression analysis confirmed these results
for both anxiety (odds ratio (OR), 8.92; 95% CI, 5.74–
13.86; p<0.001) and depression (OR, 9.70; 95% CI, 5.95–
15.82; p<0.001), with Type D being associated with a 9- to
10-fold increased risk.
In multivariable linear regression analyses, Type D
personality remained independently associated with an
increased risk of anxiety (β, 0.26; p<0.001) and depression
(β, 0.17; p<0.01), adjusting for baseline socio-demographic
and clinical characteristics and co-occurring mood state
(i.e., either anxiety or depressive symptoms). Diabetes and
younger age were both independently associated with
anxiety and depression, whereas female gender and
depressive symptoms were associated with an increased
risk of anxiety, and angina and anxiety symptoms were
independently associated with depression (results not
shown). These results were confirmed in multivariable
logistic regression analyses, with Type D being associated
with a 4- to 6-fold increased risk of anxiety (OR, 6.81; 95%
CI, 3.26–14.20; p<0.001) and depression (OR, 3.71; 95%
CI, 1.62–8.52; p<0.001), although younger age was no
longer an independent predictor of depression and angina
turned out to be a significant predictor of anxiety in these
analyses.
Table 4 Correlation matrix and principal component analysis for the subscales of the DS14, HADS and EPQ
Correlation Matrix PCA
123456 I I I
1 Social Inhibition (DS14)
a 1.00 0.41 0.78
2 Negative Affectivity (DS14)
a 0.57** 1.00 0.87 0.35
3 Depression (HADS)
a 0.46** 0.65** 1.00 0.68 0.49
4 Anxiety (HADS)
a 0.41** 0.76** 0.66** 1.00 0.92 0.16
5 Neuroticism (EPQ)
b 0.53** 0.82** 0.60** 0.76** 1.00 0.87 0.27
6 Extroversion (EPQ)
b −0.64** −0.44** −0.52** −0.33* −0.44** 10.00 −0.16 −0.92
Eigenvalues (PCA) 4.02 0.88
PCA Principal component analysis with varimax rotation based on n=117
*p<0.05; **p<0.01
aAnalysis based on n=702
bAnalysis based on n=117
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Above and Beyond Existing Psychological Measures?
To address the question of whether the Type D personality
construct merely comprised risk factors for anxiety and
depression, we examined whether the addition of Type D
personality improved the prediction of a model comprising
baseline socio-demographic and clinical characteristics, as
well as anxiety or depression, respectively. For this
purpose, we ran multivariate logistic stepwise analyses
using the enter procedure. The prediction of the model
improved significantly with the addition of Type D
personality for both anxiety (χ
2=26.85, (df=1), p<0.01)
and depression (χ
2=9.53, (df=1), p<0.01), indicating that
the Type D personality construct has added value above and
beyond existing psychological measures.
Discussion
The current study showed that the Danish version of the
Type D Scale (DS14) is a valid and reliable measure of
Type D personality in a mixed group of cardiac patients.
The two-factor structure was confirmed using confirma-
tory factor analysis, and the convergent validity was
established against scales measuring similar constructs.
The Danish DS14 was also shown to be a reliable
instrument both in terms of internal consistency and
temporal stability over 3 and 12 weeks. Type D
personality was an independent associate of both anxiety
and depression, adjusting for baseline characteristics and
co-occurring mood states, and the prediction of the
multivariable model was shown to significantly improve
when Type D was added to a model comprising socio-
demographic and clinical characteristics. Taken together,
these results support the notion that Type D personality
incurs an increased risk of mood disorders in cardiac
patients.
In the current study, Type D prevalence rates ranged
from 15% in IHD patients to 18.5% in CHF patients. These
prevalence rates are within the range of those previously
published in Type D research [2]. In addition, the
conceptualization of NA, as measured by the DS14, was
significantly associated with well-established measures of
negative affect (i.e., the HADS subscales and EPQ-N),
indicating that the DS14-NA items tap relevant aspects of
negative affect. We also showed that DS14-SI was
significantly associated with a theoretically similar con-
struct, namely EPQ-E. Although statistically there is
overlap between these theoretically similar measures, the
magnitudes of the shared variance indicate that each
measure also contains unique explanatory power. In
addition, since Type D caseness is based on personality
traits that are considered inherently stable characteristics of
the person, the temporal stability of the Type D construct is
expected to be good, an assumption which was also
confirmed by our results. This assumption was also
supported by a recent study of a large sample of post-
AMI patients over an 18-month period, which also showed
that Type D caseness was not confounded by indices of
somatic disease [20]. Taken together, the present findings
support the use of the Danish DS14 for identifying Type D
caseness in cardiac patients.
A recent review on Type D personality presents an up-
to-date overview of the empirical evidence for the
adverse impact of Type D personality on clinical events,
health status, and emotional distress, including anxiety,
depression, and posttraumatic stress disorder [2]. In the
current study, Type D was also found to be an independent
associate of anxiety and depression when adjusting for
demographic and clinical characteristics. Mood disorders
are common in cardiac patients [47–51] and comprise risk
factors for morbidity, mortality, and impaired health status
[3, 5]. In addition, there is evidence to suggest that
comorbid anxiety and depression may be especially
hazardous, since their joint impact on health status has
been shown to outweigh that of each factor on their own [9,
10]. In the present study, Type D caseness was associated
with more than a 4- to 6-fold increased risk of anxiety and
depression, suggesting that this is not just an increase of
statistical but also of clinical significance. The current
results are in line with previous studies conducted in the
Netherlands, showing that Type D personality incurs an
increased risk of anxiety and depression [2, 52], including
chronic anxiety [53], as well as 12-month onset of
depressive symptoms in patients free of depressive symp-
tomatology at 6 months [9, 10]. In addition, our analysis
showed that when controlling for socio-demographic and
clinical characteristics known to be associated with both
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104 Int. J. Behav. Med. (2009) 16:98–107anxiety and depression, Type D personality still had unique
explanatory power suggesting that the increased risk
associated with Type D personality is not just a result of
Type D personality comprising all other risk factors for
anxiety and/or depression.
Type D personality is an emerging risk factor in CVD
[2], and the clinical utility of the construct depends on
whether some form of behavioral intervention is available
to buffer against the negative impact of Type D on health
outcomes. Type D patients are in effect inefficient “copers,”
as they lack skills to reduce their high levels of emotional
distress, in part because they do not turn to their social
network for emotional support [54]. Hence, even though it
may not be possible to alter the basic personality profile of
Type D patients, participation in cardiac rehabilitation
focusing on providing new coping skills and strategies
may reduce their general levels of distress with potential
benefits to health and well-being [55]. In other words, it is
likely that Type D patients comprise a subgroup that may
require additional intervention compared to non-Type D
patients, in order to obtain the same benefits from cardiac
rehabilitation and revascularization procedures [56]. For
this reason, it is imperative that these high-risk patients can
be identified early on, using a brief, valid, and reliable
screening instrument such as the DS14.
Limitations
The results of the current study should be interpreted with
some caution. First, we could not reliably estimate the
divergent validity of the Danish version of the DS14, which
needs to be addressed in future studies. Second, we were
not able to reliably carry out a second-order CFA of the
three scales used for establishing convergent validity, due to
a limited sample size (n=117). Third, we used a self-report
measure of anxiety and depression rather than a clinical
interview. However, the HADS is a valid and reliable
measure of anxiety and depressive symptomatology with
good sensitivity and specificity against a clinical diagnostic
interview and has been shown to predict mortality in
patients referred for exercise testing [57]. An additional
advantage of the HADS is that it is not confounded by
somatic symptoms. Fourth, due to the cross-sectional
design of the study, we cannot infer causation with respect
to the impact of Type D on anxiety and depression but only
establish that there is an association.
Conclusion
In conclusion, the Danish DS14 is a valid and reliable
instrument for assessing Type D caseness in cardiac
patients. Type D personality was associated with a 4- to
6-fold increase in the risk of anxiety and depression,
adjusting for demographic and clinical risk factors. The
DS14 could be used in research and clinical practice in
order to identify high-risk patients, since Type D has been
associated with increased distress and adverse health out-
comes, including mortality. Studies are now warranted that
examine the predictive validity of the DS14 in relation to
prognosis in Danish cardiac patients.
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